Two drugs vs. one: the battle to keep blood cancer at bay
NCT ID NCT05271630
Summary
This study aims to determine which maintenance therapy works better to control multiple myeloma after a stem cell transplant. Researchers are comparing patients who receive one maintenance drug versus those who receive two drugs together. The study will track 69 patients to see which approach better prevents cancer progression and eliminates remaining cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.